PETS icon

PetMed Express

4.37 USD
-0.04
0.91%
At close Feb 21, 4:00 PM EST
1 day
-0.91%
5 days
-3.10%
1 month
-15.47%
3 months
-5.82%
6 months
41.42%
Year to date
-5.82%
1 year
-14.81%
5 years
-84.67%
10 years
-71.59%
 

About: PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.

Employees: 287

0
Funds holding %
of 7,139 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

21% more capital invested

Capital invested by funds: $34.8M [Q3] → $42.3M (+$7.48M) [Q4]

4% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 24

3.45% less ownership

Funds ownership: 45.9% [Q3] → 42.46% (-3.45%) [Q4]

11% less funds holding

Funds holding: 92 [Q3] → 82 (-10) [Q4]

30% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 23

78% less call options, than puts

Call options by funds: $1.12M | Put options by funds: $5.07M

Research analyst outlook

We haven’t received any recent analyst ratings for PETS.

Financial journalist opinion

Neutral
Seeking Alpha
1 week ago
PetMed Express, Inc. (PETS) Q3 2025 Earnings Call Transcript
PetMed Express, Inc. (NASDAQ:PETS ) Q3 2025 Earnings Conference Call February 10, 2025 4:30 PM ET Company Participants Reed Anderson - IR, ICR Sandra Campos - CEO and President Robyn D'Elia - CFO Conference Call Participants Erin Wright - Morgan Stanley Ryan Meyers - Lake Street Capital Markets Operator Greetings and welcome to PetMed Express Third Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
PetMed Express, Inc. (PETS) Q3 2025 Earnings Call Transcript
Positive
Seeking Alpha
1 week ago
PetMed Express: Dip Or Rip, A Buy After Earnings
PetMed Express stock could surge or sink after this week's quarterly earnings release, but don't read too much into this near-term event. A disappointing earnings release won't necessarily shatter the bull case, and could, in fact, push this stock back down to "back up the truck" price levels. Conversely, even if PETS rallies on strong results, this may not capture all of the potential long-term upside.
PetMed Express: Dip Or Rip, A Buy After Earnings
Positive
Zacks Investment Research
2 months ago
Here's Why PetMed (PETS) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why PetMed (PETS) is a Strong Momentum Stock
Positive
Zacks Investment Research
2 months ago
Why PetMed (PETS) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why PetMed (PETS) is a Top Momentum Stock for the Long-Term
Neutral
GlobeNewsWire
2 months ago
PetMeds® Adopts Limited Duration Shareholder Rights Plan
DELRAY BEACH, Fla., Dec. 03, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) (“PetMeds” or the “Company”), today announced that its Board of Directors (the “Board”) has adopted a limited duration shareholder rights plan to protect the best interests of all PetMeds shareholders (the “Rights Plan”).
PetMeds® Adopts Limited Duration Shareholder Rights Plan
Positive
Zacks Investment Research
3 months ago
Here's Why PetMed (PETS) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why PetMed (PETS) is a Strong Momentum Stock
Neutral
Business Wire
3 months ago
PetMeds Migrates to Ordergroove as its New Subscription and Membership Technology Partner
NEW YORK--(BUSINESS WIRE)--Ordergroove, the leading technology platform that powers subscriptions for top brands and retailers, today announced a strategic partnership with PetMed Express, Inc. (NASDAQ: PETS), the original online pet pharmacy dedicated to supporting the health and well-being of four-legged family members. This collaboration marks a significant step in modernizing and scaling PetMeds + PetCareRx's (PETS) subscription and membership capabilities to maximize operational efficiency.
PetMeds Migrates to Ordergroove as its New Subscription and Membership Technology Partner
Positive
Seeking Alpha
3 months ago
PetMed Express: Why (And Why Not) The Rebound Could Continue
PetMed Express (PETS) surged 35.8% on Nov. 7, following the online pet pharmacy's latest quarterly earnings release. Despite the massive post-earnings surge, further upside may lie ahead, if the turnaround continues. PetMed's management team is implementing a strategy change, not just cost-cutting measures, to continue improving the company's fiscal performance.
PetMed Express: Why (And Why Not) The Rebound Could Continue
Neutral
Seeking Alpha
3 months ago
PetMed Express, Inc. (PETS) Q2 2025 Earnings Call Transcript
PetMed Express, Inc. (PETS) Q2 2025 Earnings Call Transcript
PetMed Express, Inc. (PETS) Q2 2025 Earnings Call Transcript
Positive
Zacks Investment Research
3 months ago
PetMed (PETS) Surpasses Q2 Earnings Estimates
PetMed (PETS) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.06 per share. This compares to break-even earnings per share a year ago.
PetMed (PETS) Surpasses Q2 Earnings Estimates
Charts implemented using Lightweight Charts™